Novavax (NVAX) EBT Margin (2010 - 2026)

Novavax (NVAX) posted quarterly EBT Margin of 6.1% for Q1 2026, down 8408.0% year-over-year from 0.07% in Q1 2025, and down 150.11% quarter-over-quarter from 12.17% in Q4 2025.

Novavax (NVAX) EBT Margin (2010 - 2026) Analysis & Trends

Novavax's EBT Margin history runs 17 years deep, the most recent figure standing at 6.1% for Q1 2026.

  • In Q1 2026, EBT Margin fell 8408.0% year-over-year to 6.1%; the TTM figure through Mar 2026 stood at 16.2% (down 5512.0% YoY), while the FY2025 annual figure was 39.36%, up 6525.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 6.1%, down from 12.17% in the prior quarter.
  • The five-year high for EBT Margin was 77.98% in Q1 2025, with the low at 361.6% in Q1 2023.
  • The 5-year median for EBT Margin is 51.63% (2022), against an average of 75.51%.
  • The sharpest annual moves came in 2022 and 2023: EBT Margin soared 32177 bps in 2022, then sank 39088 bps in 2023.
  • Novavax's EBT Margin stood at 51.63% in 2022, then retreated by 17 bps to 60.65% in 2023, then slumped by 37 bps to 83.32% in 2024, then jumped by 115 bps to 12.17% in 2025, then plunged by 150 bps to 6.1% in 2026.
  • Business Quant data shows NVAX's EBT Margin at 6.1% in Q1 2026, 12.17% in Q4 2025, and 288.22% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 35.61%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 34.77%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 18.33%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -94.22%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 13.77%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -2.67%
10 Novavax 1.33 Bn 607.37 Mn 42.45 Mn -91.14%

Historic Data

Download Data
DateValue
Jun 30, 2026 -91.14%
Mar 31, 2026 -6.10%
Dec 31, 2025 12.17%
Sep 30, 2025 -288.22%
Jun 30, 2025 61.40%
Mar 31, 2025 77.98%
Dec 31, 2024 -83.32%
Sep 30, 2024 -144.75%
Jun 30, 2024 39.61%
Mar 31, 2024 -154.80%
Dec 31, 2023 -60.65%
Sep 30, 2023 -70.31%
Jun 30, 2023 13.63%
Mar 31, 2023 -361.60%
Dec 31, 2022 -51.63%
Sep 30, 2022 -22.62%
Jun 30, 2022 -273.80%
Mar 31, 2022 29.27%
Dec 31, 2021 -373.39%
Sep 30, 2021 -176.91%